Updated: March 19, 2021 BPOM encourages self-reliance in human cell-based drug production Must Read Nationalindonesianupdates.com_admin - November 6, 2024President Prabowo seeks firm action against four crimes Nationalindonesianupdates.com_admin - November 6, 2024Expect substantial agreement from ICA-CEPA talks: trade ministry Nationalindonesianupdates.com_admin - November 6, 2024President Prabowo inks 47 regulations on ministries, agencies The Drug and Food Control Agency (BPOM) has unveiled a guide to develop and produce human cell-based medicines to encourage domestic pharmaceutical companies to become self-reliant in drug production. “This guide also … Previous articleKadin confirms 3.5 million registered for self-funded vaccinationNext articleGovernment should not delay and pay holiday allowance for 2021: KSPI Latest News National - November 6, 2024President Prabowo seeks firm action against four crimesIndonesia's President Prabowo Subianto has urged law enforcement officers to take firm action against four major ... National Expect substantial agreement from ICA-CEPA talks: trade ministry - November 6, 2024 National President Prabowo inks 47 regulations on ministries, agencies - November 6, 2024 National President Prabowo awaiting US election results: spokesperson - November 6, 2024 National Indonesia eyes UNESCO recognition for three cultural heritages - November 6, 2024 More Articles Like This President Jokowi calls for a shift in defense policy BREAKING NEWS - October 5, 2021 Black & Veatch management consulting chosen to help drive SCG International’s electric vehicle transition in Thailand BREAKING NEWS - October 5, 2021 Australia successfully goes live With Everbridge Public Warning platform countrywide, representing official launch of the Australian Government’s next-generation national population alerting system BREAKING NEWS - October 5, 2021 PPKM outside Java-Bali extended till Oct 18 BREAKING NEWS - October 4, 2021
The Drug and Food Control Agency (BPOM) has unveiled a guide to develop and produce human cell-based medicines to encourage domestic pharmaceutical companies to become self-reliant in drug production.